CervoMed Inc —— 季度现金流量表 (NASDAQ:CRVO) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 43.08 M38.58 M38.08 M30.61 M22.88 M 负债总额 3.88 M3.94 M4.64 M4.6 M4.66 M 权益总额 39.2 M34.63 M33.44 M26.01 M18.22 M 负债及股东权益总额 43.08 M38.58 M38.08 M30.61 M22.88 M 总债务 ————— 净债务 —————

新闻

H.C. Wainwright重申CervoMed股票评级,基于会议数据

H.C. Wainwright reiterates CervoMed stock rating on conference data

CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates

Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com

CervoMed确定第三阶段痴呆症试验50毫克剂量

CervoMed sets 50mg dose for phase 3 dementia trial

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?

CervoMed的neflamapimod入选英国ALS试验平台

CervoMed’s neflamapimod selected for UK ALS trial platform

Cantor Fitzgerald 给予 CervoMed 股票"增持"评级

Cantor Fitzgerald initiates CervoMed stock with Overweight rating

CervoMed股价在有前景的痴呆症药物试验结果后飙升